课题基金 / 基金详情

Meningioma: Risk Factors and Quality of Life

Meningioma: Risk Factors and Quality of Life
脑膜瘤:危险因素和生活质量
批准号:
7825342
负责人:
DORA ILYASOVA
金额:
$9.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-26 至 2012-03-31

项目摘要

项目成果

DORA ILYASOVA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): No large-scale study within the United States has examined any aspect of the epidemiology of intracranial meningiomas, a lesion which accounts for up to 25% of all primary intracranial neoplasms. We propose to conduct a population-based case/control study of meningioma within the states of Connecticut, Massachusetts, North Carolina, and Texas as well as the San Francisco Bay area under the mechanism of an integrated R01 (Note that identical applications are submitted for all five sites). Cases will be selected using rapid case ascertainment and will include all male; and female individuals diagnosed with a histologically confirmed intra-cranial meningioma between the ages of 20 and 79 years from 7/1/2006 through 6/30/2010 in the above listed regions. Control subjects will be identified via random-digit dial methods and matched to the cases by sex, ethnicity, geographic location, and five-year age category. Study subjects will be administered a telephone questionnaire to collect information on the two primary categories of risk, exposure to ionizing radiation and hormones as well as additional risk factors such as family history of meningioma and other tumors, cell-phone utilization, and head trauma as well as questions on outcome and quality of life. Parraffin-embedded tumor tissue blocks will be obtained for case subjects to allow for 1) a uniform histological review, and 2) immunohistochemical testing for estrogen, progesterone, androgen and MIB-1 receptors. Blood or buccal specimens will be collected from all study subjects for testing of DNA polymorphisms in DNA repair and cell cycle genes. This study represents the first concentrated effort to examine environmental and genetic risk factors for meningioma.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/cncr.26625
发表时间: 2012-09-15
期刊: Cancer
影响因子: 6.2
作者: [Claus EB, Calvocoressi L, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M]
通讯作者: Wrensch M
Assessment of autoantibodies to meningioma in a population-based study.
在基于人群的研究中评估脑膜瘤自身抗体。
DOI: 10.1093/aje/kws221
发表时间: 2013
期刊: American journal of epidemiology
影响因子: 5
作者: [Wiemels,JosephL, Bracci,PaigeM, Wrensch,Margaret, Schildkraut,Joellen, Bondy,Melissa, Pfefferle,Jon, Zhou,Mi, Sison,Jennette, Calvocoressi,Lisa, Claus,ElizabethB]
通讯作者: Claus,ElizabethB
Dental x-rays and risk of meningioma: response to Drs. Calnon, Jorgensen, and White.
牙科 X 光检查和脑膜瘤风险:对 Drs 的反应。
DOI: 10.1002/cncr.27708
发表时间: 2013
期刊: Cancer
影响因子: 6.2
作者: [Claus,ElizabethB, Wiemels,Joseph, Wrensch,Margaret]
通讯作者: Wrensch,Margaret
DOI: 10.1002/cncr.30975
发表时间: 2018-01-01
期刊: Cancer
影响因子: 6.2
作者: [Benz LS, Wrensch MR, Schildkraut JM, Bondy ML, Warren JL, Wiemels JL, Claus EB]
通讯作者: Claus EB
Urinary F2-isoprostanes as a new biomarker for the risk of type 2 diabetes
  • 批准号:
    7761765
  • 项目类别:
  • 资助金额:
    $25.96万
  • 财政年份:
    2009
  • 负责人:
    DORA ILYASOVA
  • 依托单位:
Urinary F2-isoprostanes as a new biomarker for the risk of type 2 diabetes
  • 批准号:
    7582571
  • 项目类别:
  • 资助金额:
    $19.89万
  • 财政年份:
    2009
  • 负责人:
    DORA ILYASOVA
  • 依托单位:
Urinary F2-Isoprostanes As A New Biomarker For The Risk Of Type 2 Diabetes
  • 批准号:
    8018105
  • 项目类别:
  • 资助金额:
    $26.39万
  • 财政年份:
    2009
  • 负责人:
    DORA ILYASOVA
  • 依托单位:
海外基金